NYSEARCA:AMS - NYSE Arca - US0295951059 - Common Stock - Currency: USD
NYSEARCA:AMS (3/7/2025, 8:04:53 PM)
2.7475
-0.01 (-0.45%)
The current stock price of AMS is 2.7475 USD. In the past month the price decreased by -11.37%. In the past year, price increased by 0.37%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
CI | THE CIGNA GROUP | 11.74 | 87.86B | ||
CVS | CVS HEALTH CORP | 12.24 | 83.63B | ||
LH | LABCORP HOLDINGS INC | 17.37 | 21.18B | ||
DGX | QUEST DIAGNOSTICS INC | 19.46 | 19.48B | ||
FMS | FRESENIUS MEDICAL CARE-ADR | 15.78 | 14.07B | ||
DVA | DAVITA INC | 15.48 | 11.76B | ||
BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 115.35 | 11.05B | ||
CHE | CHEMED CORP | 25.75 | 8.72B | ||
HIMS | HIMS & HERS HEALTH INC | 66.57 | 7.99B | ||
OPCH | OPTION CARE HEALTH INC | 27.88 | 5.62B | ||
CRVL | CORVEL CORP | 26.02 | 5.59B | ||
GH | GUARDANT HEALTH INC | N/A | 4.85B |
American Shared Hospital Services engages in leasing radiosurgery and radiation therapy equipment to healthcare providers. The company is headquartered in San Francisco, California and currently employs 13 full-time employees. Its segments include Leasing, and Retail. The Leasing segment comprises the Company’s medical equipment leasing. The Retail segment comprises facilities in Peru and Ecuador. Its products include MR Guided Radiation Therapy Linacs, Advanced Digital Linear Accelerators, Proton Beam Radiation Therapy Systems (PBRT), Brachytherapy systems and suites, and through the Company’s subsidiary, GK Financing LLC., the Leksell Gamma Knife product and services. PBRT is an alternative to traditional external beam, photon-based radiation delivered by linear accelerators. The Gamma Knife treats selected malignant and benign brain tumors, arteriovenous malformations, and functional disorders including trigeminal neuralgia (facial pain). The company also provides the equipment and planning, installation, reimbursement and marketing support services.
AMERICAN SHARED HOSPITAL SER
601 Montgomery Street, Suite 1112
San Francisco CALIFORNIA 94111 US
CEO: Raymond C. Stachowiak
Employees: 31
Company Website: https://ashs.com/
Investor Relations: http://www.ashs.com/investors.html
Phone: 14157885300
The current stock price of AMS is 2.7475 USD. The price decreased by -0.45% in the last trading session.
The exchange symbol of AMERICAN SHARED HOSPITAL SER is AMS and it is listed on the NYSE Arca exchange.
AMS stock is listed on the NYSE Arca exchange.
5 analysts have analysed AMS and the average price target is 4.95 USD. This implies a price increase of 80.05% is expected in the next year compared to the current price of 2.7475. Check the AMERICAN SHARED HOSPITAL SER stock analysts ratings, price target forecast and up-and down grades for more detailed information.
AMERICAN SHARED HOSPITAL SER (AMS) has a market capitalization of 17.64M USD. This makes AMS a Nano Cap stock.
AMERICAN SHARED HOSPITAL SER (AMS) currently has 31 employees.
AMERICAN SHARED HOSPITAL SER (AMS) has a resistance level at 3.02. Check the full technical report for a detailed analysis of AMS support and resistance levels.
The Revenue of AMERICAN SHARED HOSPITAL SER (AMS) is expected to grow by 29.6% in the next year. Check the estimates tab for more information on the AMS EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AMS does not pay a dividend.
AMERICAN SHARED HOSPITAL SER (AMS) will report earnings on 2025-03-27, after the market close.
The PE ratio for AMERICAN SHARED HOSPITAL SER (AMS) is 68.69. This is based on the reported non-GAAP earnings per share of 0.04 and the current share price of 2.7475 USD. Check the full fundamental report for a full analysis of the valuation metrics for AMS.
The outstanding short interest for AMERICAN SHARED HOSPITAL SER (AMS) is 0.76% of its float. Check the ownership tab for more information on the AMS short interest.
ChartMill assigns a fundamental rating of 5 / 10 to AMS. There are concerns on the financial health of AMS while its profitability can be described as average.
Over the last trailing twelve months AMS reported a non-GAAP Earnings per Share(EPS) of 0.04. The EPS increased by 752.43% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 15.74% | ||
ROA | 6.21% | ||
ROE | 14.87% | ||
Debt/Equity | 0.58 |
ChartMill assigns a Buy % Consensus number of 80% to AMS. The Buy consensus is the average rating of analysts ratings from 5 analysts.
For the next year, analysts expect an EPS growth of 940% and a revenue growth 29.6% for AMS